Knee osteoarthritis (OA) is a degenerative condition that affects millions worldwide, causing pain, stiffness, and reduced mobility. Platelet-rich plasma (PRP) injections have gained popularity as a regenerative treatment option, offering a non-surgical solution to manage OA symptoms. However, research suggests that the effectiveness of PRP may depend significantly on the platelet dosage used.

Why PRP Dosing Matters

Recent studies indicate a dose-dependent response to PRP injections in knee OA [Berrigan et al, 2024; Berrigan et al, 2025]. Higher platelet doses appear to provide better clinical outcomes, particularly in terms of functional improvement and chondroprotection. A systematic review found that patients receiving platelet counts exceeding 10 billion had significantly improved outcomes compared to those receiving lower doses.

Key Findings from Research

• Optimal Dose for Knee OA: Research suggests that a total platelet dose exceeding 10 billion is necessary for meaningful improvements in function and pain relief in knee osteoarthritis.
• Multi-Injection vs. Single High-Dose Injection: Some studies indicate that a single high-dose PRP injection may be as effective as multiple lower-dose injections.
• Variability in PRP Preparation: Different PRP processing techniques and commercial kits result in varied platelet concentrations, impacting efficacy.

Clinical Implications

For clinicians, standardizing PRP preparation and ensuring adequate platelet dosing is crucial. Patients should be aware that not all PRP injections are equal, and choosing a provider who understands the importance of dosing can influence treatment success.

Conclusion

Dosing plays a critical role in PRP therapy for knee OA. Higher platelet doses (>10 billion) may yield better functional and pain-related outcomes, reinforcing the need for standardized PRP protocols. Learn more about high-dose PRP for knee osteoarthritis:

(781) 591-7855

info@BSBortho.com

20 Walnut St

Suite 14

Wellesley MA 02481

References

• Berrigan W, Tao F, Kopcow J, Park AL, Allen I, Tahir P, Reddy A, Bailowitz Z. The Effect of Platelet Dose on Outcomes after Platelet Rich Plasma Injections for Musculoskeletal Conditions: A Systematic Review and Meta-Analysis. Curr Rev Musculoskelet Med. 2024 Dec;17(12):570-588.
• Berrigan WA, Bailowitz Z, Park A, Reddy A, Liu R, Lansdown D. A Greater Platelet Dose May Yield Better Clinical Outcomes for Platelet-Rich Plasma in the Treatment of Knee Osteoarthritis: A Systematic Review. Arthroscopy. 2025 Mar;41(3):809-817.e2.